Fairvalue-Calculator Fairvalue-Calculator
EN DE

Norsyn Crop Technology Co (001231) Fair Value & Analysis

Basic Materials · CN · Market cap 2.0B CNY

Price¥19.97
Fair Value¥12.04
Upside-39.7%
Quality95/100
Evidence: High Range ¥8.23 – ¥14.94

Fair value as of: Jun 25, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Norsyn Crop Technology Co (001231) currently trades at ¥19.97, while our model-based Fair Value estimate is ¥12.04 — implying the stock looks roughly 39.7% overvalued today. We read business quality at 95/100 (high quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

Norsyn Crop Technology Co., Ltd. engages in the research, development, production, and sale of pesticide preparation products in China and internationally. It offers insecticides, fungicides, and herbicides, as well as plant growth regulator, plant nutrition, and seed coating agent products. It also provides fluphenacamide and bifenazate TC, methoxyfenozide technical, and phenylpeptide amino acid technical. The company was formerly known as Shaanxi Nongshim Crop Science & Technology Co., Ltd. Norsyn Crop Technology Co., Ltd. was incorporated in 2006 and is headquartered in Xi'an, China.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is Norsyn Crop Technology Co (001231) undervalued?
As of Jun 25, 2026, our model estimates a fair value of ¥12.04 versus a price of ¥19.97 — about −40% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 001231?
Our 21-model fair value for Norsyn Crop Technology Co is ¥12.04 (as of Jun 25, 2026), built from audited fundamentals. The current price is ¥19.97.
What is the quality score of 001231?
Norsyn Crop Technology Co has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.